Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Nov 23 EFFECT Notice of effectiveness
- 22 Nov 23 POS AM Prospectus update (post-effective amendment)
- 1 Nov 23 POS AM Prospectus update (post-effective amendment)
- 18 Jul 23 424B4 Prospectus supplement with pricing info
- 17 Jul 23 EFFECT Notice of effectiveness
- 13 Jul 23 F-1/A Registration statement (foreign) (amended)
-
12 Jul 23 F-1/A Registration statement (foreign) (amended)
- 28 Jun 23 FWP Free writing prospectus
- 28 Jun 23 F-1/A Registration statement (foreign) (amended)
- 16 Jun 23 F-1 Registration statement (foreign)
GLMD similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form F-1, of our report dated March 29, 2023 relating to the financial statements of Galmed Pharmaceuticals Ltd. (“the Company”) appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2022. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Brightman Almagor Zohar & Co. | |
Brightman Almagor Zohar & Co., | |
Certified Public Accountants | |
A firm in the Deloitte Global Network |
Tel Aviv, Israel
July 12, 2023